InterCure Ltd Investor Relations Material
Latest events
Q4 2022
InterCure Ltd
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from InterCure Ltd
Access all reports
InterCure Ltd is a pharmaceutical company focused on the production and distribution of medical cannabis products. Through its subsidiary, Canndoc, the company cultivates and manufactures pharmaceutical-grade cannabis used for medical treatments. InterCure offers a range of cannabis-based products, including oils, flowers, and other formulations designed for therapeutic purposes. The company partners with international healthcare and cannabis companies to expand its product offerings and distribution channels in global markets where medical cannabis is regulated. The company is headquartered in Herzliya, Israel, and its shares are listed on the NASDAQ.
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
INCR
Country
πΊπΈ United States